Doctors were mostly anticipating to forestall complications and relapses when they gave immature women a medicine to keep their skeleton clever during breast cancer treatment. Seven years later, they found it did some-more than that: The bone drug softened survival, as most as many chemotherapies do.
News referensi http://news.yahoo.com/fda-advisers-stand-behind-ortho-evra-patch-222327355.html Also On shopping
No comments:
Post a Comment